Review of 46 human studies links prenatal acetaminophen to higher ADHD/ASD risk; evidence is heterogeneous; cohort effect sizes are generally modest but larger in some biomarker studies; authors advise cautious, short‑term use under medical guidance.
Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates
KFF Health News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.